Search

Your search keyword '"Elisabetta, Cosi"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Elisabetta, Cosi" Remove constraint Author: "Elisabetta, Cosi"
61 results on '"Elisabetta, Cosi"'

Search Results

2. COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES

Catalog

Books, media, physical & digital resources

4. Peculiar, poorly known, rare congenital bleeding disorders presenting thrombotic events: an understudied chapter of molecular, blood coagulation defects

7. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

8. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

9. Systemic Mastocytosis and Essential Thrombocythemia: Case Report and Literature Overview

10. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

11. Peculiar, poorly known, rare congenital bleeding disorders presenting thrombotic events: an understudied chapter of molecular, blood coagulation defects

12. Thrombotic Events in Homozygotes with a Proven or Highly Probable Arg304Gln Factor VII Mutation (FVII Padua)1): Only Limited Replacement Therapy is Needed in Case of Surgery

14. Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome

15. Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX)

16. Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study

17. A structure–function analysis in patients with prekallikrein deficiency

18. New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice

21. Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States

22. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

23. Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations

24. Use and prescription appropriateness of drugs for peptic ulcer and gastrooesophageal reflux disease in hospitalized older people

25. The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance

26. Pulmonary embolism in congenital bleeding disorders

27. Thrombotic and hemorrhagic complications in idiopathic erythrocytosis

28. Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period

30. Inappropriate prescription of benzodiazepines in acutely hospitalized older patients

31. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

32. Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study

33. African and African-American Contribution to the Knowledge of the FVII Padua (Arg304Gln) Defect

35. Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed

36. Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis

38. Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders

39. Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation

40. Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders

41. HFE mutations in idiopathic erythrocytosis

42. Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period*

43. Factor X Friuli Coagulation Disorder: Almost 50 Years Later

44. Prethrombotic, prothrombotic, thrombophilic states, hypercoagulable state, thrombophilia etc.: semantics should be respected even in medical papers

45. Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds

46. Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)

47. Unravelling Genetic Mechanisms of Erythrocytosis: A Real-Life Experience from a Single Center

48. Correction to: New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice

49. Idiopathic erythrocytosis: a study of a large cohort with a long follow-up

50. Thrombotic risk correlates with mutational status in true essential thrombocythemia